期刊文献+

羊水甲胎蛋白浓度与胎儿畸形的关系 被引量:4

The relationship between the level of amniotic fl uid alpha-fetoprotein and fetal malformation
原文传递
导出
摘要 目的了解羊水甲胎蛋白(AFP)浓度与胎儿畸形的关系。方法对2007年1月至2012年5月在本院进行羊膜腔穿刺的孕17~23w孕妇5262例,运用酶联免疫吸附法对羊水进行AFP检测,根据其2.5倍中位数倍数(MoM)值进行分组,观察孕妇的妊娠结局,分析羊水AFP升高与胎儿畸形的关系。结果1.各孕周羊水AFP的2.5MoM值分别为:孕17w 41150ng/ml,18w38395ng/ml,19w 34995ng/ml,20w 31700ng/ml,21w 29655ng/ml,22w 26940ng/ml,23w 21800ng/ml。2.羊水AFP≥2.5MoM时发生率明显升高的胎儿畸形为:神经管缺陷,颈部淋巴管瘤,死胎。结论羊水AFP≥2.5MoM时,临床诊断除考虑神经管缺陷,还应警惕是否有颈部淋巴管瘤或死胎可能。羊水AFP≥2.5MoM对于诊断神经管缺陷的特异度及阴性预测价值较高,但灵敏度及阳性预测价值一般,需结合系统彩超排除相关畸形。 Objective: To investigate the relationship between the level of amniotic fluid alpha-fetoprotein (AFP) and fetal malformation. Methods: A total of 5262 women were taken amniotic fluid sample for the measurement of alpha-fetoprotein by enzyme linked immunosorbent assay during 17 to 23 weeks of gestation from January 2007 to May 2012. According the level of 2.5 multiple of median (MoM) of AFP, we divided the women into two groups. In the end, the pregnancy outcome was record and analyzed. The difference of incidence of fetal malformation in the two groups was compared. Results: 1.The 2.5 MoM of amniotic fluid AFP in different gestational weeks are: 41150ng/ml in 17 weeks, 38395ng/ml in 18 weeks, 34995ng/ml in 19 weeks, 31700ng/ ml in 20 weeks, 28535ng/ml in 21 weeks, 24120ng/ml in 22 weeks, 20043ng/ml in 23 weeks. 2. The fetal malformations related to elevated amniotic fluid AFP were: neural tube defects (NTDs), cystic hygroma, fetal demise. Conclusion: Except NTDs, cystic hygroma and fetal demise should be considered when amniotic fluid AFP≥2.5 MoM. Specificity and negative predictive value of anmiotie fluid AFP are quite high in diagnosis of NTDs, but sensitivity and positive predictive value are not high enough. Ultrasound should be needed for further diagnosis.
出处 《中国优生与遗传杂志》 2014年第8期105-106,112,共3页 Chinese Journal of Birth Health & Heredity
基金 广西卫生厅自筹经费科研项目(Z2005103)
关键词 甲胎蛋白 羊水 神经管缺陷 颈部淋巴管瘤 死胎 Alpha-fetoprotein Amniotic fluid Neural tube defects Cystic hygroma Fetal demise
  • 相关文献

参考文献14

  • 1Zhu L,H Ling. National rttral tube defocts prevention program in Ckina[J]. Food Nutr Bull, 2008, 29(2 Sappl): 196-204.
  • 2Wang ZP, et al. The effectiveness of prenatal serum biomarker screening for emral tube defects i second trimester pregnant women: a meta-analysis[J]. Prenat Diagn, 2009, 29(10): 960-965.
  • 3杨灿锋,王峻峰,朱云霞,陈道桢.15230例孕中期唐氏筛查产前诊断的临床应用价值[J].实用妇产科杂志,2011,27(2):142-145. 被引量:45
  • 4宋婕萍,易松.孕中期母血清AFP检测产前筛查胎儿神经管缺陷的研究[J].中国优生与遗传杂志,2008,16(5):97-97. 被引量:14
  • 5Iodi Dashe, Diane Twickler, Rigoberto Samtos-Ramos,et al. Aipha--fetoprotein detection of neural tube defects and the impact of stadard ultrasouad[J]. American Journal of Obstetrics and Gynecology, 2006, 195: 1623-1628.
  • 6Milunsky A, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data[J]. Am J Obstet Gynecol, 1989, 161(2): 291-297.
  • 7丁萍,王雪超,张爱青,孙玉萍.羊水及血清中甲胎蛋白在正常与异常妊娠中测定的意义[J].中国优生与遗传杂志,1999,7(4):64-65. 被引量:1
  • 8孙念怙,等.正常胎儿及无脑儿羊水内甲胎蛋白测定[J].中华妇产科杂志,1978,13(1):34-37.
  • 9Reichler A, et al. Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein[J]. Am J Obstet Gynecol,1994, 171(4):1052-1055.
  • 10Brock DJ, Sutcliffe RG. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida[J]. Lancet,1972, 29(2): 197- 199.

二级参考文献49

  • 1孙含枯 等.正常胎儿及无脑儿羊水内甲胎蛋白测定[J].中华妇产科杂志,1978,13(1):34-37.
  • 2Eloranta ML, Heinonen S, Kirkinen P. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and HCG [ J]. Acta-Obstet Gynecol Scand, 2000, 79(6) : 548 -552.
  • 3Summers AM, Farrell SA, Huang T, et al. Maternal serum screening in ontario using the triple marker test [ J ]. J Med Screen, 2003,10 (2) :107 -111.
  • 4Wald N J, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome [J ] . J Med Screen, 1997,4(2) :181 -246.
  • 5Cuckle HS, Vanlith JM. App rop ridte biochemical parameters in first-trimester screening for Down syndrome [ J ]. Prenat Diagn, 1999, 19(6) : 505 -512.
  • 6Candenas M, Villa R, Femandez, Collar R, et al. Maternal serum alpha - fetoprotein screening for neurahube defects. Repor to faprogram with more than 30000 screened pregnancies. [ J ] , Acta Obstet Gynecal Stand, 1995,74 (4) ;266 - 9.
  • 7Chan A, Robertson EF, Haan EA, et al. The sensitivity of ultrasound and serum alpha - fetoprotein in population - based antenatal screening for neurahube defects. South Australia 1986 - 1991. [ J] , Br J Obstet Gynaecol, 1995,102 (5) ;370 - 6.
  • 8Jacob A Canick,Leonard H Kellner,Allan T Bombard.Prenatalscreening for open neural tube defects. Clinics in Laboratory Medicine . 2003
  • 9S Hirose,DL Farmer.Fetal surgery for myelomeningocele. Clinics in Perinatology . 2009
  • 10Hogge,WA,Thiagarajah,S,II,Ferguson,JE,Schnatterly,PT,Jr,Harbert,GM.The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects. American Journal of Obstetrics and Gynecology . 1989

共引文献65

同被引文献28

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部